Plain-English translation of NCT04934982 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a minimally invasive laparoscopic surgery (or robotic-assisted surgery) works as well as traditional open abdominal surgery for treating early-stage cervical cancer. Researchers want to compare how well each approach works, how long patients survive, and how patients feel and recover after surgery.
Doctors want to know if the newer, less invasive surgical approach is just as effective as the traditional open surgery for this type of cancer. This matters because minimally invasive surgery often means shorter recovery time and fewer complications, but it's important to make sure it doesn't compromise cancer treatment.
You would be randomly assigned to receive either minimally invasive laparoscopic (or robotic-assisted) surgery or traditional open abdominal surgery to remove your cervix and surrounding tissue. After surgery, you would be followed by the research team over time with check-ups and imaging tests to monitor your recovery, watch for any side effects, and track how well the cancer treatment is working.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China
Sponsor
Hua Jiang
Collaborators
Children's Hospital of Fudan University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Enrollment target
~690 participants
Started
September 2021
Primary completion
June 2024
Age range
21 Years – 70 Years
Sex
Female only
Last updated on clinicaltrials.gov in November 2021.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hua Jiang, PHD
The Obstetrics and Gynecology Hospital of Fudan University